688513 苑东生物
午间休市 09-11 11:29:58
资讯
新帖
简况
苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会
证券日报 · 09-08 20:16
苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会
苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%
证券之星 · 09-08 17:58
苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%
22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前
同花顺 · 09-08
22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
证券之星 · 09-07
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
每周股票复盘:苑东生物(688513)累计回购138.65万股
证券之星 · 09-06
每周股票复盘:苑东生物(688513)累计回购138.65万股
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
证券之星 · 09-04
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
苑东生物:截至9月3日公司累计回购股份1386528股
证券日报网 · 09-03
苑东生物:截至9月3日公司累计回购股份1386528股
股市必读:苑东生物新发布《苑东生物:关于股份回购进展公告》
证券之星 · 09-02
股市必读:苑东生物新发布《苑东生物:关于股份回购进展公告》
苑东生物(688513)披露股份回购进展公告,8月31日股价上涨0.96%
证券之星 · 08-31
苑东生物(688513)披露股份回购进展公告,8月31日股价上涨0.96%
每周股票复盘:苑东生物(688513)拟回购注销25.7454万股
证券之星 · 08-30
每周股票复盘:苑东生物(688513)拟回购注销25.7454万股
股市必读:苑东生物新发布《苑东生物:2026年第二次临时股东会会议资料》
证券之星 · 08-28
股市必读:苑东生物新发布《苑东生物:2026年第二次临时股东会会议资料》
股市必读:苑东生物(688513)8月24日披露最新机构调研信息
证券之星 · 08-25
股市必读:苑东生物(688513)8月24日披露最新机构调研信息
8月24日苑东生物跌5.82%,博时主题LOF基金重仓该股
证券之星 · 08-24
8月24日苑东生物跌5.82%,博时主题LOF基金重仓该股
股市必读:苑东生物新发布《苑东生物:第四届董事会第十五次会议决议公告》
证券之星 · 08-21
股市必读:苑东生物新发布《苑东生物:第四届董事会第十五次会议决议公告》
苑东生物(688513)披露关于召开2026年第二次临时股东会的通知,8月20日股价上涨6.56%
证券之星 · 08-20
苑东生物(688513)披露关于召开2026年第二次临时股东会的通知,8月20日股价上涨6.56%
8月19日苑东生物跌5.09%,博时主题LOF基金重仓该股
证券之星 · 08-19
8月19日苑东生物跌5.09%,博时主题LOF基金重仓该股
每周股票复盘:苑东生物(688513)HP-002片启动I/II期临床试验
证券之星 · 08-16
每周股票复盘:苑东生物(688513)HP-002片启动I/II期临床试验
股市必读:苑东生物新发布《苑东生物:关于自愿披露HP-002片启动I/II期临床试验并完成首例受试者入组给药的公告》
证券之星 · 08-13
股市必读:苑东生物新发布《苑东生物:关于自愿披露HP-002片启动I/II期临床试验并完成首例受试者入组给药的公告》
苑东生物(688513.SH):HP-002片启动I/II期临床试验并完成首例受试者入组给药
智通财经 · 08-12
苑东生物(688513.SH):HP-002片启动I/II期临床试验并完成首例受试者入组给药
每周股票复盘:苑东生物(688513)盐酸尼卡地平拟中选集采
证券之星 · 08-09
每周股票复盘:苑东生物(688513)盐酸尼卡地平拟中选集采
暂无数据
公司概况
公司名称:
成都苑东生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-09-02
主营业务:
成都苑东生物制药股份有限公司的主营业务是化学原料药、高端化学药及生物药研发、生产和销售。公司的主要产品是化学制剂、化学原料药、CMO/CDMO、技术服务及转让。公司是国家高新技术企业,拥有“国家企业技术中心”、“博士后科研工作站”、“四川省固态药物工程技术研究中心”等多个创新平台,先后被认定为国家技术创新示范企业、国家企业技术中心、国家知识产权示范企业、国家绿色工厂,多次荣登中国化药企业百强、中国医药创新企业百强等榜单。
发行价格:
44.36
{"stockData":{"symbol":"688513","market":"SH","secType":"STK","nameCN":"苑东生物","latestPrice":44.2,"timestamp":1789097398000,"preClose":46.53,"halted":0,"volume":1736738,"delay":0,"changeRate":-0.0501,"floatShares":177000000,"shares":177000000,"eps":1.5705,"marketStatus":"午间休市","change":-2.33,"latestTime":"09-11 11:29:58","open":46.22,"high":46.9,"low":43.88,"amount":77305700,"amplitude":0.0649,"askPrice":44.24,"askSize":2,"bidPrice":44.2,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.5705,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789102800000},"marketStatusCode":3,"adr":0,"adjPreClose":46.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":51.18,"lowLimit":41.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":176532256,"isCdr":false,"pbRate":2.8,"roa":"--","peRate":28.143903,"roe":"4.33%","epsLYR":1.63,"committee":0.856716,"marketValue":7803000000,"turnoverRate":0.0098,"status":1,"floatMarketCap":7803000000},"requestUrl":"/m/hq/s/688513/tweets","defaultTab":"tweets","newsList":[{"id":"2665378020","title":"苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378020","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665378020?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:16","pubTimestamp":1788869760,"startTime":"0","endTime":"0","summary":"9月8日,苑东生物发布公告称,公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","IBBQ","KSTR","159992","MEDX","BK1574","BK1161","688513","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332184","title":"苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665332184?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:58","pubTimestamp":1788861491,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘,苑东生物报收于45.39元,较前一交易日下跌1.63%,最新总市值为80.13亿元。该股当日开盘46.32元,最高46.5元,最低44.91元,成交额达8179.78万元,换手率为1.02%。公司于近日披露《2026年第二次临时股东会决议公告》,显示其于2026年9月7日召开2026年第二次临时股东会,审议通过《关于回购注销2024年员工持股计划部分股份的议案》和《关于终止部分募集资金投资项目并将剩余募集资金永久补充流动资金的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665134383","title":"22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2665134383","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665134383?lang=zh_cn&edition=full","pubTime":"2026-09-08 07:51","pubTimestamp":1788825060,"startTime":"0","endTime":"0","summary":"数据显示,9月8日,22家公司共发布22个股票回购相关进展。其中,4家公司首次披露股票回购预案,7家公司回购方案获股东大会通过,5家公司披露股票回购实施进展,6家公司回购方案已实施完毕。 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679676232.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679676232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0189","688513","BK0238","BK0239","002911","BK0252","603517"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362793","title":"股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362793?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:15","pubTimestamp":1788714911,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,苑东生物报收于44.5元,下跌1.07%,换手率0.87%,成交量1.53万手,成交额6842.8万元。公司公告汇总:苑东生物完成股份回购,累计回购1,386,528股,占总股本0.7854%,成交总金额6,075.35万元,回购实施完毕并进入后续处置程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665650323","title":"每周股票复盘:苑东生物(688513)累计回购138.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665650323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665650323?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:46","pubTimestamp":1788633972,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,苑东生物报收于44.5元,较上周的43.58元上涨2.11%。本周,苑东生物9月4日盘中最高价报45.33元。截至2026年8月末,公司累计回购股份1,386,528股,占总股本的0.7854%,累计回购金额为60,753,547.16元,回购价格区间为40.56元/股至46.99元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880632","title":"股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664880632?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:56","pubTimestamp":1788458175,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘,苑东生物报收于44.98元,上涨2.02%,换手率0.76%,成交量1.35万手,成交额6020.18万元。公司公告汇总:苑东生物完成股份回购,累计回购1,386,528股,成交总金额6,075.35万元,回购实施完毕。本次回购符合原定方案,未对公司经营、财务状况及控制权产生重大影响。已回购股份存放于回购专用证券账户,将在披露回购结果公告12个月后通过集中竞价交易方式出售,若3年内未转让完毕,剩余股份将予以注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664088108","title":"苑东生物:截至9月3日公司累计回购股份1386528股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664088108","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664088108?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:02","pubTimestamp":1788444120,"startTime":"0","endTime":"0","summary":"证券日报网讯9月3日,苑东生物发布公告称,截至2026年9月3日,本次股份回购的期限已届满,公司已实施的股份回购符合公司股份回购方案的要求。公司通过集中竞价交易方式累计回购公司股份1,386,528股,占当前公司总股本的比例为0.7854%,购买的最高价为46.99元/股,最低价为40.56元/股,成交总金额为人民币60,753,547.16元(不含印花税、交易佣金等交易费用)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqnck4227986.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqnck4227986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863168","title":"股市必读:苑东生物新发布《苑东生物:关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863168?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:43","pubTimestamp":1788284590,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年8月末,苑东生物累计回购股份1,386,528股,占总股本0.7854%,累计回购金额60,753,547.16元;8月单月回购330,864股,成交金额14,645,214.96元。公司公告汇总苑东生物:关于股份回购进展公告成都苑东生物制药股份有限公司于2026年6月4日披露股份回购方案,拟使用5,000万元至10,000万元自有资金,以不超过80元/股的价格通过集中竞价交易方式回购股份,回购期限为2026年6月4日至9月3日,用途为维护公司价值及股东权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663900118","title":"苑东生物(688513)披露股份回购进展公告,8月31日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663900118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663900118?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:35","pubTimestamp":1788186938,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,苑东生物报收于44.0元,较前一交易日上涨0.96%,最新总市值为77.67亿元。该股当日开盘42.96元,最高44.27元,最低42.43元,成交额达7034.71万元,换手率为0.92%。近日,苑东生物发布《关于股份回购进展公告》。2026年8月单月回购330,864股,成交金额14,645,214.96元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663504868","title":"每周股票复盘:苑东生物(688513)拟回购注销25.7454万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663504868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663504868?lang=zh_cn&edition=full","pubTime":"2026-08-30 05:52","pubTimestamp":1788040334,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,苑东生物报收于43.58元,较上周的45.56元下跌4.35%。本周,苑东生物8月24日盘中最高价报46.0元。本周关注点公司公告汇总:苑东生物拟回购注销25.7454万股未解锁股份公司公告汇总:公司拟终止“生物药研究项目”并永久补流超亿元募集资金公司公告汇总成都苑东生物制药股份有限公司拟回购注销2024年员工持股计划第二个解锁期未解锁的25.7454万股股份,回购价格为21.63元/股加上银行同期存款利息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662321900","title":"股市必读:苑东生物新发布《苑东生物:2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662321900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662321900?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:41","pubTimestamp":1787877688,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘,苑东生物报收于44.3元,上涨0.52%,换手率0.79%,成交量1.4万手,成交额6104.79万元。公司公告汇总苑东生物:2026年第二次临时股东会会议资料成都苑东生物制药股份有限公司拟回购注销2024年员工持股计划第二个解锁期未解锁的25.7454万股股份,回购价格为21.63元/股加上银行同期存款利息。同时,公司拟终止“生物药研究项目”,并将剩余募集资金10,024.03万元及其利息和理财收益永久补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800015990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662320517","title":"股市必读:苑东生物(688513)8月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662320517?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:39","pubTimestamp":1787600377,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,苑东生物报收于42.91元,下跌5.82%,换手率1.62%,成交量2.87万手,成交额1.25亿元。当日关注点交易信息汇总:8月24日主力资金净流出53.79万元,占总成交额0.43%。机构调研要点:8月21日未开展特定对象调研及电话会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500008034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224889","title":"8月24日苑东生物跌5.82%,博时主题LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224889?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:35","pubTimestamp":1787560503,"startTime":"0","endTime":"0","summary":"证券之星消息,8月24日苑东生物跌5.82%,收盘报42.91元,换手率1.62%,成交量2.87万手,成交额1.25亿元。石炯在任的基金产品包括:博时研究优选混合A,管理时间为2023年9月1日至今,期间收益率为7.45%;博时主题LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513","160505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661346122","title":"股市必读:苑东生物新发布《苑东生物:第四届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661346122","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661346122?lang=zh_cn&edition=full","pubTime":"2026-08-21 03:40","pubTimestamp":1787254822,"startTime":"0","endTime":"0","summary":"公司公告汇总:公司将于2026年9月7日召开2026年第二次临时股东会,审议回购注销员工持股计划部分股份及终止部分募投项目两项议案,股权登记日为2026年8月31日。上述两项议案尚需提交公司股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100003767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238295","title":"苑东生物(688513)披露关于召开2026年第二次临时股东会的通知,8月20日股价上涨6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238295","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660238295?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:38","pubTimestamp":1787236694,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘,苑东生物报收于48.1元,较前一交易日上涨6.56%,最新总市值为84.91亿元。该股当日开盘47.13元,最高50.61元,最低46.11元,成交额达2.53亿元,换手率为2.95%。近日,苑东生物发布《关于召开2026年第二次临时股东会的通知》。公告显示,公司将于2026年9月7日召开2026年第二次临时股东会,会议采取现场与网络投票结合方式,网络投票通过上海证券交易所系统进行。股权登记日为2026年8月31日,登记时间截至2026年9月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468104","title":"8月19日苑东生物跌5.09%,博时主题LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660468104?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:48","pubTimestamp":1787129281,"startTime":"0","endTime":"0","summary":"证券之星消息,8月19日苑东生物跌5.09%,收盘报45.14元,换手率1.57%,成交量2.77万手,成交额1.28亿元。石炯在任的基金产品包括:博时研究优选混合A,管理时间为2023年9月1日至今,期间收益率为9.37%;博时主题LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900028517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239","160505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175174","title":"每周股票复盘:苑东生物(688513)HP-002片启动I/II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175174","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175174?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:53","pubTimestamp":1786816391,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,苑东生物报收于49.68元,较上周的49.81元下跌0.26%。本周,苑东生物8月13日盘中最高价报52.54元。苑东生物当前最新总市值87.7亿元,在化学制药板块市值排名59/149,在两市A股市值排名2042/5207。HP-002片为新一代具有透脑能力的BTK靶向PROTAC分子,临床前研究显示其对多种BTK突变株具有优异体外活性和体内药效,且口服生物利用度及血脑屏障穿透能力优于对照分子。该临床试验已于2026年5月获国家药监局批准,目前I期剂量递增阶段已启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659749904","title":"股市必读:苑东生物新发布《苑东生物:关于自愿披露HP-002片启动I/II期临床试验并完成首例受试者入组给药的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659749904","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659749904?lang=zh_cn&edition=full","pubTime":"2026-08-13 02:15","pubTimestamp":1786558515,"startTime":"0","endTime":"0","summary":"公司公告汇总:苑东生物控股子公司HP-002片启动I/II期临床试验并完成首例受试者入组给药。公司公告汇总苑东生物:关于自愿披露HP-002片启动I/II期临床试验并完成首例受试者入组给药的公告成都苑东生物制药股份有限公司控股子公司上海超阳药业自主研发的化学药品1类创新药HP-002片,近日完成用于治疗复发或难治的B细胞非霍奇金淋巴瘤的I/II期临床试验首例受试者入组给药。该临床试验已于2026年5月获国家药监局批准,目前I期剂量递增阶段已启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920366","title":"苑东生物(688513.SH):HP-002片启动I/II期临床试验并完成首例受试者入组给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920366","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658920366?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:31","pubTimestamp":1786523474,"startTime":"0","endTime":"0","summary":"智通财经APP讯,苑东生物 发布公告,公司控股子公司上海超阳药业有限公司自主研发的化学药品1类创新药HP002片正在开展用于治疗复发或难治的B细胞非霍奇金淋巴瘤I/II期临床试验,于近日完成首例受试者入组给药。截至本公告披露日,该研究I期剂量递增阶段已完成首例受试者入组给药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HP","PSYK","BK4092","BK0239","688513","BMED","IBBQ","IBBJ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673090","title":"每周股票复盘:苑东生物(688513)盐酸尼卡地平拟中选集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673090","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673090?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:11","pubTimestamp":1786212670,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,苑东生物报收于49.81元,较上周的44.68元上涨11.48%。本周,苑东生物8月7日盘中最高价报50.0元。公司公告汇总苑东生物及全资子公司硕德药业于2026年7月31日参加第十二批全国药品集中采购投标,盐酸尼卡地平注射液和比索洛尔氨氯地平片拟中选,采购周期至2029年12月31日。拟中选产品尚处公示期,最终结果及合同签订存在不确定性。2026年7月单月回购110,402股,成交金额4,883,400.26元。本次回购符合相关规定及方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789100189122,"stockEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.0714},{"period":"3month","weight":-0.0058},{"period":"6month","weight":-0.1813},{"period":"1year","weight":-0.1361},{"period":"ytd","weight":-0.2365}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0001},{"period":"3month","weight":-0.0241},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.032},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都苑东生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6589人(较上一季度增加20.99%)","perCapita":"26791股","listingDate":"2020-09-02","address":"四川省成都市郫都区高新区西源大道8号","registeredCapital":"17653万元","survey":" 成都苑东生物制药股份有限公司的主营业务是化学原料药、高端化学药及生物药研发、生产和销售。公司的主要产品是化学制剂、化学原料药、CMO/CDMO、技术服务及转让。公司是国家高新技术企业,拥有“国家企业技术中心”、“博士后科研工作站”、“四川省固态药物工程技术研究中心”等多个创新平台,先后被认定为国家技术创新示范企业、国家企业技术中心、国家知识产权示范企业、国家绿色工厂,多次荣登中国化药企业百强、中国医药创新企业百强等榜单。","listedPrice":44.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"苑东生物,688513,苑东生物股票,苑东生物股票老虎,苑东生物股票老虎国际,苑东生物行情,苑东生物股票行情,苑东生物股价,苑东生物股市,苑东生物股票价格,苑东生物股票交易,苑东生物股票购买,苑东生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}